Literature DB >> 23622355

Main steps of skeletal muscle development in the human: morphological analysis and ultrastructural characteristics of developing human muscle.

Norma Beatriz Romero1, Monica Mezmezian, Anna Fidziańska.   

Abstract

During embryogenesis, paraxial mesoderm undergoes segmentation into somites, progressing from head to tail. Somites differentiate into dermomyotomes, then into dermatomes and myotomes. Some head muscles derive from the anterior paraxial and precordal mesoderm. Between 10 and 13 weeks of gestation, the fusion of myoblasts generates primary myotubes with central nuclei, and the latter form the second generation of myotubes which requires active innervation. Nicotinamide adenine dinucleotide dehydrogenase-tetrazolium reductase appears before succinate dehydrogenase, and ATPase shows an intermediary activity. β-Sarcoglycan appears by 7 gestational weeks and α-sarcoglycan by 10-12 weeks. β-Spectrin, dystrophin, and utrophin appear by 9 weeks, vimentin and desmin appear by 10 weeks and stain strongly between 10 and 15 weeks. Slow, embryonic myosin heavy chain (MHC) isoenzymes appear before 15 weeks, whereas fetal fast MCH occur later (15-18 weeks). Myotubes become myofibers with peripheral nuclei between 15 and 18 weeks. Large muscle fibers (Wohlfart B) are visible by 20-21 weeks, Wohlfart A by 21-25 weeks. Perimysium surrounds compacted and grouped fibers by 24 weeks, and utrophin disappears, whereas dystrophin stains intensely. At 29 weeks, type I fibers are visible, and by 31-33 weeks they are mature for ATPase staining. Three types of type II fibers can be seen. Vimentin disappears between 15 and 30 weeks, while desmin remains weakly positive at birth.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23622355     DOI: 10.1016/B978-0-444-59565-2.00002-2

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  11 in total

1.  Dysregulation of the NRG1/ERBB pathway causes a developmental disorder with gastrointestinal dysmotility in humans.

Authors:  Thuy-Linh Le; Louise Galmiche; Jonathan Levy; Pim Suwannarat; Debby Mei Hellebrekers; Khomgrit Morarach; Franck Boismoreau; Tom Ej Theunissen; Mathilde Lefebvre; Anna Pelet; Jelena Martinovic; Antoinette Gelot; Fabien Guimiot; Amanda Calleroz; Cyril Gitiaux; Marie Hully; Olivier Goulet; Christophe Chardot; Severine Drunat; Yline Capri; Christine Bole-Feysot; Patrick Nitschké; Sandra Whalen; Linda Mouthon; Holly E Babcock; Robert Hofstra; Irenaeus Fm de Coo; Anne-Claude Tabet; Thierry J Molina; Boris Keren; Alice Brooks; Hubert Jm Smeets; Ulrika Marklund; Christopher T Gordon; Stanislas Lyonnet; Jeanne Amiel; Nadège Bondurand
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

Review 2.  Prognostic impact of sarcopenia in children with cancer: a focus on the psoas muscle area (PMA) imaging in the clinical practice.

Authors:  Silvia Triarico; Emanuele Rinninella; Maria Cristina Mele; Marco Cintoni; Giorgio Attinà; Antonio Ruggiero
Journal:  Eur J Clin Nutr       Date:  2021-10-07       Impact factor: 4.884

Review 3.  Impact of placental insufficiency on fetal skeletal muscle growth.

Authors:  Laura D Brown; William W Hay
Journal:  Mol Cell Endocrinol       Date:  2016-03-16       Impact factor: 4.102

4.  Guinea pig models for translation of the developmental origins of health and disease hypothesis into the clinic.

Authors:  Janna L Morrison; Kimberley J Botting; Jack R T Darby; Anna L David; Rebecca M Dyson; Kathryn L Gatford; Clint Gray; Emilio A Herrera; Jonathan J Hirst; Bona Kim; Karen L Kind; Bernardo J Krause; Stephen G Matthews; Hannah K Palliser; Timothy R H Regnault; Bryan S Richardson; Aya Sasaki; Loren P Thompson; Mary J Berry
Journal:  J Physiol       Date:  2018-05-30       Impact factor: 5.182

5.  Evidence for Altered Ca2+ Handling in Growth Associated Protein 43-Knockout Skeletal Muscle.

Authors:  Giusy A Caprara; Caterina Morabito; Stefano Perni; Riccardo Navarra; Simone Guarnieri; Maria A Mariggiò
Journal:  Front Physiol       Date:  2016-10-26       Impact factor: 4.566

6.  Skeletal Muscle Resident Progenitor Cells Coexpress Mesenchymal and Myogenic Markers and Are Not Affected by Chronic Heart Failure-Induced Dysregulations.

Authors:  R I Dmitrieva; T A Lelyavina; M Y Komarova; V L Galenko; O A Ivanova; P A Tikanova; N V Khromova; A S Golovkin; M A Bortsova; A Sergushichev; M Yu Sitnikova; A A Kostareva
Journal:  Stem Cells Int       Date:  2019-01-03       Impact factor: 5.443

7.  Mitochondrial function in skeletal myofibers is controlled by a TRF2-SIRT3 axis over lifetime.

Authors:  Jérôme D Robin; Maria-Sol Jacome Burbano; Han Peng; Olivier Croce; Jean Luc Thomas; Camille Laberthonniere; Valerie Renault; Liudmyla Lototska; Mélanie Pousse; Florent Tessier; Serge Bauwens; Waiian Leong; Sabrina Sacconi; Laurent Schaeffer; Frédérique Magdinier; Jing Ye; Eric Gilson
Journal:  Aging Cell       Date:  2020-01-28       Impact factor: 9.304

8.  Antioxidant Treatment and Induction of Autophagy Cooperate to Reduce Desmin Aggregation in a Cellular Model of Desminopathy.

Authors:  Eva Cabet; Sabrina Batonnet-Pichon; Florence Delort; Blandine Gausserès; Patrick Vicart; Alain Lilienbaum
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

9.  Muscle histopathology in nebulin-related nemaline myopathy: ultrastrastructural findings correlated to disease severity and genotype.

Authors:  Edoardo Malfatti; Vilma-Lotta Lehtokari; Johann Böhm; Josine M De Winter; Ursula Schäffer; Brigitte Estournet; Susana Quijano-Roy; Soledad Monges; Fabiana Lubieniecki; Remi Bellance; Mai Thao Viou; Angéline Madelaine; Bin Wu; Ana Lía Taratuto; Bruno Eymard; Katarina Pelin; Michel Fardeau; Coen A C Ottenheijm; Carina Wallgren-Pettersson; Jocelyn Laporte; Norma B Romero
Journal:  Acta Neuropathol Commun       Date:  2014-04-12       Impact factor: 7.801

10.  The breaking and making of healthy adult human skeletal muscle in vivo.

Authors:  Abigail L Mackey; Michael Kjaer
Journal:  Skelet Muscle       Date:  2017-11-07       Impact factor: 4.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.